Literature DB >> 22042930

Immunosuppression and the abdominal aortic aneurysm: Doctor Jekyll or Mister Hyde?

Jan H N Lindeman1, Ton J Rabelink, J Hajo van Bockel.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2011        PMID： 22042930     DOI： 10.1161/CIRCULATIONAHA.110.008573

Source DB:  PubMed          Journal:  Circulation        ISSN： 0009-7322            Impact factor:   29.690


× No keyword cloud information.
  16 in total

Review 1.  Understanding the pathogenesis of abdominal aortic aneurysms.

Authors:  Helena Kuivaniemi; Evan J Ryer; James R Elmore; Gerard Tromp
Journal:  Expert Rev Cardiovasc Ther       Date:  2015

2.  DAPT, a potent Notch inhibitor regresses actively growing abdominal aortic aneurysm via divergent pathways.

Authors:  Chetan P Hans; Neekun Sharma; Rishabh Dev; Jones M Blain; Jeff Tonniges; Gunjan Agarwal
Journal:  Clin Sci (Lond)       Date:  2020-06-26       Impact factor: 6.124

3.  Deficiency of IL12p40 (Interleukin 12 p40) Promotes Ang II (Angiotensin II)-Induced Abdominal Aortic Aneurysm.

Authors:  Neekun Sharma; Rishabh Dev; Anthony M Belenchia; Annayya R Aroor; Adam Whaley-Connell; Lakshmi Pulakat; Chetan P Hans
Journal:  Arterioscler Thromb Vasc Biol       Date:  2019-02       Impact factor: 8.311

4.  Activation of the vitamin D receptor selectively interferes with calcineurin-mediated inflammation: a clinical evaluation in the abdominal aortic aneurysm.

Authors:  Arend Jan Nieuwland; Vivianne Bc Kokje; Olivier H Koning; Jaap F Hamming; Karoly Szuhai; Frans H J Claas; Jan H N Lindeman
Journal:  Lab Invest       Date:  2016-05-30       Impact factor: 5.662

5.  Genetic and pharmacologic disruption of interleukin-1β signaling inhibits experimental aortic aneurysm formation.

Authors:  William F Johnston; Morgan Salmon; Gang Su; Guanyi Lu; Matthew L Stone; Yunge Zhao; Gary K Owens; Gilbert R Upchurch; Gorav Ailawadi
Journal:  Arterioscler Thromb Vasc Biol       Date:  2013-01-03       Impact factor: 8.311

Review 6.  Novel mechanisms of abdominal aortic aneurysms.

Authors:  Hong Lu; Debra L Rateri; Dennis Bruemmer; Lisa A Cassis; Alan Daugherty
Journal:  Curr Atheroscler Rep       Date:  2012-10       Impact factor: 5.113

Review 7.  Clonal expansion of T cells in abdominal aortic aneurysm: a role for doxycycline as drug of choice?

Authors:  Albert M Kroon; Jan-Willem Taanman
Journal:  Int J Mol Sci       Date:  2015-05-18       Impact factor: 5.923

8.  No beneficial effect of general and specific anti-inflammatory therapies on aortic dilatation in Marfan mice.

Authors:  Romy Franken; Stijntje Hibender; Alexander W den Hartog; Teodora Radonic; Carlie J M de Vries; Aeilko H Zwinderman; Maarten Groenink; Barbara J M Mulder; Vivian de Waard
Journal:  PLoS One       Date:  2014-09-19       Impact factor: 3.240

9.  ACE inhibitors potently reduce vascular inflammation, results of an open proof-of-concept study in the abdominal aortic aneurysm.

Authors:  Kim E Kortekaas; C Arnoud Meijer; Jan Willem Hinnen; Ronald L Dalman; Baohui Xu; Jaap F Hamming; Jan H Lindeman
Journal:  PLoS One       Date:  2014-12-04       Impact factor: 3.240

10.  Systematic Evaluation of the Cellular Innate Immune Response During the Process of Human Atherosclerosis.

Authors:  Rogier A van Dijk; Kevin Rijs; Anouk Wezel; Jaap F Hamming; Frank D Kolodgie; Renu Virmani; Alexander F Schaapherder; Jan H N Lindeman
Journal:  J Am Heart Assoc       Date:  2016-06-16       Impact factor: 5.501
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.